BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34708325)

  • 1. Natural History Studies and Clinical Trial Readiness for Genetic Developmental and Epileptic Encephalopathies.
    Palmer EE; Howell K; Scheffer IE
    Neurotherapeutics; 2021 Jul; 18(3):1432-1444. PubMed ID: 34708325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epileptic encephalopathies and progressive neurodegeneration.
    Guerrini R; Conti V
    Rev Neurol (Paris); 2024 May; 180(5):363-367. PubMed ID: 38582661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-advocate-led global coalition adapting fit-for-purpose outcomes measures to assure meaningful inclusion of DEEs in clinical trials.
    Hecker J; Conecker G; Chapman C; Hommer R; Ludwig NN; Sevinc G; Te S; Wojnaroski M; Downs J; Berg AT
    Ther Adv Rare Dis; 2024; 18():26330040241249762. PubMed ID: 38911512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum.
    Bonardi CM; Heyne HO; Fiannacca M; Fitzgerald MP; Gardella E; Gunning B; Olofsson K; Lesca G; Verbeek N; Stamberger H; Striano P; Zara F; Mancardi MM; Nava C; Syrbe S; Buono S; Baulac S; Coppola A; Weckhuysen S; Schoonjans AS; Ceulemans B; Sarret C; Baumgartner T; Muhle H; Portes VD; Toulouse J; Nougues MC; Rossi M; Demarquay G; Ville D; Hirsch E; Maurey H; Willems M; de Bellescize J; Altuzarra CD; Villeneuve N; Bartolomei F; Picard F; Hornemann F; Koolen DA; Kroes HY; Reale C; Fenger CD; Tan WH; Dibbens L; Bearden DR; Møller RS; Rubboli G
    Brain; 2021 Dec; 144(12):3635-3650. PubMed ID: 34114611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dystonia as a prominent presenting feature in developmental and epileptic encephalopathies: A case series.
    Dzinovic I; Škorvánek M; Necpál J; Boesch S; Švantnerová J; Wagner M; Havránková P; Pavelekova P; Haň V; Janzarik WG; Berweck S; Diebold I; Kuster A; Jech R; Winkelmann J; Zech M
    Parkinsonism Relat Disord; 2021 Sep; 90():73-78. PubMed ID: 34399161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the genetic and phenotypic relevance of KCNB1 variants in developmental and epileptic encephalopathies: 27 new patients and overview of the literature.
    Bar C; Barcia G; Jennesson M; Le Guyader G; Schneider A; Mignot C; Lesca G; Breuillard D; Montomoli M; Keren B; Doummar D; Billette de Villemeur T; Afenjar A; Marey I; Gerard M; Isnard H; Poisson A; Dupont S; Berquin P; Meyer P; Genevieve D; De Saint Martin A; El Chehadeh S; Chelly J; Guët A; Scalais E; Dorison N; Myers CT; Mefford HC; Howell KB; Marini C; Freeman JL; Nica A; Terrone G; Sekhara T; Lebre AS; Odent S; Sadleir LG; Munnich A; Guerrini R; Scheffer IE; Kabashi E; Nabbout R
    Hum Mutat; 2020 Jan; 41(1):69-80. PubMed ID: 31513310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRM7-related disorder: five additional patients from three independent families and review of the literature.
    Januel L; Chatron N; Rivier-Ringenbach C; Cabet S; Labalme A; Sahin Y; Darvish H; Kruer M; Bakhtiari S; Sanlaville D; de Sainte Agathe JM; Lesca G
    Eur J Med Genet; 2024 Feb; 67():104893. PubMed ID: 38070825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yield of exome sequencing in patients with developmental and epileptic encephalopathies and inconclusive targeted gene panel.
    Sedlackova L; Sterbova K; Vlckova M; Seeman P; Zarubova J; Marusic P; Krsek P; Krijtova H; Musilova A; Lassuthova P
    Eur J Paediatr Neurol; 2024 Jan; 48():17-29. PubMed ID: 38008000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological Biomarkers in Genetic Epilepsies.
    Armstrong C; Marsh ED
    Neurotherapeutics; 2021 Jul; 18(3):1458-1467. PubMed ID: 34642905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and clinical variations of developmental epileptic encephalopathies.
    Kaya Özçora GD; Söbü E; Gümüş U
    Neurol Res; 2023 Mar; 45(3):226-233. PubMed ID: 36731496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCN2A-Developmental and Epileptic Encephalopathies: Challenges to trial-readiness for non-seizure outcomes.
    Berg AT; Palac H; Wilkening G; Zelko F; Schust Meyer L
    Epilepsia; 2021 Jan; 62(1):258-268. PubMed ID: 33236786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Developmental and Epileptic Encephalopathy and of Intellectual Disability and Epilepsy in Children.
    Poke G; Stanley J; Scheffer IE; Sadleir LG
    Neurology; 2023 Mar; 100(13):e1363-e1375. PubMed ID: 36581463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical and genetic landscape of developmental and epileptic encephalopathies in Egyptian children.
    Elkhateeb N; Issa MY; Elbendary HM; Elnaggar W; Ramadan A; Rafat K; Kamel M; Abdel-Ghafar SF; Amer F; Hassaan HM; Trunzo R; Pereira C; Abdel-Hamid MS; D'Arco F; Bauer P; Bertoli-Avella AM; Girgis M; Gleeson JG; Zaki MS; Selim L
    Clin Genet; 2024 May; 105(5):510-522. PubMed ID: 38221827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic landscape of the epileptic encephalopathies of infancy and childhood.
    McTague A; Howell KB; Cross JH; Kurian MA; Scheffer IE
    Lancet Neurol; 2016 Mar; 15(3):304-16. PubMed ID: 26597089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and genetic spectrum of SCN8A-related disorders, treatment options, and outcomes.
    Gardella E; Møller RS
    Epilepsia; 2019 Dec; 60 Suppl 3():S77-S85. PubMed ID: 31904124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy.
    Tran Mau-Them F; Guibaud L; Duplomb L; Keren B; Lindstrom K; Marey I; Mochel F; van den Boogaard MJ; Oegema R; Nava C; Masurel A; Jouan T; Jansen FE; Au M; Chen AH; Cho M; Duffourd Y; Lozier E; Konovalov F; Sharkov A; Korostelev S; Urteaga B; Dickson P; Vera M; Martínez-Agosto JA; Begemann A; Zweier M; Schmitt-Mechelke T; Rauch A; Philippe C; van Gassen K; Nelson S; Graham JM; Friedman J; Faivre L; Lin HJ; Thauvin-Robinet C; Vitobello A
    Genet Med; 2019 Apr; 21(4):1008-1014. PubMed ID: 30166628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental and epilepsy spectrum of KCNB1 encephalopathy with long-term outcome.
    Bar C; Kuchenbuch M; Barcia G; Schneider A; Jennesson M; Le Guyader G; Lesca G; Mignot C; Montomoli M; Parrini E; Isnard H; Rolland A; Keren B; Afenjar A; Dorison N; Sadleir LG; Breuillard D; Levy R; Rio M; Dupont S; Negrin S; Danieli A; Scalais E; De Saint Martin A; El Chehadeh S; Chelly J; Poisson A; Lebre AS; Nica A; Odent S; Sekhara T; Brankovic V; Goldenberg A; Vrielynck P; Lederer D; Maurey H; Terrone G; Besmond C; Hubert L; Berquin P; Billette de Villemeur T; Isidor B; Freeman JL; Mefford HC; Myers CT; Howell KB; Rodríguez-Sacristán Cascajo A; Meyer P; Genevieve D; Guët A; Doummar D; Durigneux J; van Dooren MF; de Wit MCY; Gerard M; Marey I; Munnich A; Guerrini R; Scheffer IE; Kabashi E; Nabbout R
    Epilepsia; 2020 Nov; 61(11):2461-2473. PubMed ID: 32954514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental and epileptic encephalopathies: recognition and approaches to care.
    Raga S; Specchio N; Rheims S; Wilmshurst JM
    Epileptic Disord; 2021 Feb; 23(1):40-52. PubMed ID: 33632673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum.
    Guerrini R; Conti V; Mantegazza M; Balestrini S; Galanopoulou AS; Benfenati F
    Physiol Rev; 2023 Jan; 103(1):433-513. PubMed ID: 35951482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias.
    Helbig KL; Lauerer RJ; Bahr JC; Souza IA; Myers CT; Uysal B; Schwarz N; Gandini MA; Huang S; Keren B; Mignot C; Afenjar A; Billette de Villemeur T; Héron D; Nava C; Valence S; Buratti J; Fagerberg CR; Soerensen KP; Kibaek M; Kamsteeg EJ; Koolen DA; Gunning B; Schelhaas HJ; Kruer MC; Fox J; Bakhtiari S; Jarrar R; Padilla-Lopez S; Lindstrom K; Jin SC; Zeng X; Bilguvar K; Papavasileiou A; Xing Q; Zhu C; Boysen K; Vairo F; Lanpher BC; Klee EW; Tillema JM; Payne ET; Cousin MA; Kruisselbrink TM; Wick MJ; Baker J; Haan E; Smith N; Sadeghpour A; Davis EE; Katsanis N; ; Corbett MA; MacLennan AH; Gecz J; Biskup S; Goldmann E; Rodan LH; Kichula E; Segal E; Jackson KE; Asamoah A; Dimmock D; McCarrier J; Botto LD; Filloux F; Tvrdik T; Cascino GD; Klingerman S; Neumann C; Wang R; Jacobsen JC; Nolan MA; Snell RG; Lehnert K; Sadleir LG; Anderlid BM; Kvarnung M; Guerrini R; Friez MJ; Lyons MJ; Leonhard J; Kringlen G; Casas K; El Achkar CM; Smith LA; Rotenberg A; Poduri A; Sanchis-Juan A; Carss KJ; Rankin J; Zeman A; Raymond FL; Blyth M; Kerr B; Ruiz K; Urquhart J; Hughes I; Banka S; ; Hedrich UBS; Scheffer IE; Helbig I; Zamponi GW; Lerche H; Mefford HC
    Am J Hum Genet; 2018 Nov; 103(5):666-678. PubMed ID: 30343943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.